Keywords: neurosearch, gets, 10m, gsk, uk, drug, major

NeuroSearch gets $10M from GSK

Article | 04 April 2005

Print This

UK drug major GlaxoSmithKline will initiate Phase II clinical studies of Danish group NeuroSearch's NS2359 (GSK372475) to assess the agent's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in